Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy
about
Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@ast
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@en
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@nl
type
label
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@ast
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@en
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@nl
prefLabel
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@ast
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@en
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@nl
P2860
P356
P1476
Polifeprosan 20, 3.85% carmust ...... ctives on a low-burden therapy
@en
P2093
Lawrence Kleinberg
P2860
P304
P356
10.2147/PPA.S93020
P407
P577
2016-11-24T00:00:00Z